Skip to main content

Table 1 Baseline characteristics

From: Fibroblast growth factor 23 is associated with proteinuria and smoking in chronic kidney disease: An analysis of the MASTERPLAN cohort

Variable

N(%) = 604(100%)

Gender (male)

417(69%)

Age (yrs)

60.2(± 12.5)

BMI (kg/m 2 )

26.5(24.3-29.4)

Race (Caucasian)

560(92.7)

Cause of CKD

 

   Diabetic nephropathy

65(10.8%)

   Renovascular

188(31.1%)

   Glomerular disease

109(18%)

   Interstitial disease

57(9.4%)

   Congenital (incl PKD)

62(10.3%)

   Unknown

123(20.4%)

History of CVD

178(29.5%)

Diabetes Mellitus

144(23.8%)

Hypertension

433(71.7%)

Smoking

145(24%)

Systolic BP (mmHg)

136(± 21)

Diastolic BP (mmHg)

78(± 11)

Creatinine (μmol/l)

184(± 71)

eGFR (MDRD, ml/min/1.73 m 2 )

36.8(± 13.9)

Total cholesterol (mmol/l)

4.8(± 1.0)

Proteinuria (g/24 hours)

0.3(0.1-0.9)

Phosphate (mmol/l)

1.12(± 0.26)

Calcium (mmol/l)

2.38(± 0.14)

PTH (pmol/l)

8.3(5.6-14.4)

cFGF23 (RU/ml)

116(67-203)

Medication

 

   Active vitamin D (any)

135(22.4)

   Phosphate binders (any)

56(9.3)

  1. Values are given as N (%), mean and standard deviations (± SD) for normally distributed data and medians and interquartile ranges (25%-75%) for skewed data.
  2. CKD: chronic kidney disease; PKD: polycystic kidney disease; CVD: cardiovascular disease; BP: blood pressure; eGFR: estimated glomerular filtration rate; MDRD: four-point MDRD formula.